REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 13, 2013
Insider Transaction Report
Form 4
Hwang Si Moon
Director
Transactions
- Award
Stock Options (right-to-buy)
2013-06-11+60,000→ 60,000 totalExercise: $0.50Exp: 2023-06-11→ Common Stock (60,000 underlying)
Holdings
- 341,198
Common Stock
- 7,000(indirect: By son)
Common Stock
- 7,000(indirect: By daughter)
Common Stock
- 7,000(indirect: By daughter)
Common Stock
- 20,000
Stock Options (right-to-buy)
Exercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]These options vest and become exercisable in full on June 11, 2014.
- [F2]These options vest and become exercisable in full on June 18, 2013.